CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,087
- in 3 filings
Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 76 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-09 | Paul Robert Chief Medical Officer | Option exercise | +2,083 | $10.14 | $21K | 232,894 |
| 2021-03-09 | Paul Robert Chief Medical Officer | Sale | −19,175 | $18.12 | $347K | 213,719 |
| 2021-03-09 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −17,092 | 200,358 | ||
| 2021-03-09 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −2,083 | 58,334 | ||
| 2021-02-09 | Paul Robert Chief Medical Officer | Option exercise | +17,091 | $8.16 | $139K | 230,810 |
| 2021-02-09 | Paul Robert Chief Medical Officer | Option exercise | +2,084 | $10.14 | $21K | 232,894 |
| 2021-02-09 | Paul Robert Chief Medical Officer | Sale | −19,175 | $20.81 | $399K | 213,719 |
| 2021-02-09 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −17,091 | 217,450 | ||
| 2021-02-09 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −2,084 | 60,417 | ||
| 2021-01-26 | Paul Robert Chief Medical Officer | Option exercise | +23,142 | $8.16 | $189K | 236,861 |
| 2021-01-26 | Paul Robert Chief Medical Officer | Option exercise | +4,166 | $10.14 | $42K | 241,027 |
| 2021-01-26 | Paul Robert Chief Medical Officer | Sale | −27,308 | $18.00 | $492K | 213,719 |
| 2021-01-26 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −23,142 | 234,541 | ||
| 2021-01-26 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −4,166 | 62,501 | ||
| 2021-01-25 | Paul Robert Chief Medical Officer | Option exercise | +27,916 | $8.16 | $228K | 241,635 |
| 2021-01-25 | Paul Robert Chief Medical Officer | Option exercise | +2,084 | $10.14 | $21K | 243,719 |
| 2021-01-25 | Paul Robert Chief Medical Officer | Sale | −30,000 | $18.01 | $540K | 213,719 |
| 2021-01-25 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −27,916 | 257,683 | ||
| 2021-01-25 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −2,084 | 66,667 | ||
| 2021-01-20 | Paul Robert Chief Medical Officer | Option exercise | +6,484 | $8.16 | $53K | 220,203 |
Page 22 of 23 · 454 trades